当前位置:
X-MOL 学术
›
J. Am. Coll. Cardiol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Valve Choice for TAVR: Much Left to re-SOLVE
Journal of the American College of Cardiology ( IF 21.7 ) Pub Date : 2024-11-06 , DOI: 10.1016/j.jacc.2024.09.1216 Neel M. Butala, Amar Krishnaswamy
中文翻译:
TAVR 的瓣膜选择:还有很多需要重新解决
Butala 博士获得了美国心脏协会和 Boettcher 基金会的资助;已收到 Shockwave Medical、Boston Scientific、Catch Bio 和 HiLabs 的咨询费;拥有 Catch Bio 和 HiLabs 的所有权权益;并收到了美敦力和 Edwards 的食品/饮料。Krishnaswamy 博士报告说,他与本文的内容没有任何关系要披露。
更新日期:2024-11-06
Journal of the American College of Cardiology ( IF 21.7 ) Pub Date : 2024-11-06 , DOI: 10.1016/j.jacc.2024.09.1216 Neel M. Butala, Amar Krishnaswamy
Section snippets
Funding Support and Author Disclosures
Dr Butala has received grants from the American Heart Association and the Boettcher Foundation; has received consulting fees from Shockwave Medical, Boston Scientific, Catch Bio, and HiLabs; has an ownership interest in Catch Bio and HiLabs; and has received food/beverages from Medtronic and Edwards. Dr Krishnaswamy has reported that he has no relationships relevant to the contents of this paper to disclose.中文翻译:
TAVR 的瓣膜选择:还有很多需要重新解决
部分片段
资金支持和作者披露
Butala 博士获得了美国心脏协会和 Boettcher 基金会的资助;已收到 Shockwave Medical、Boston Scientific、Catch Bio 和 HiLabs 的咨询费;拥有 Catch Bio 和 HiLabs 的所有权权益;并收到了美敦力和 Edwards 的食品/饮料。Krishnaswamy 博士报告说,他与本文的内容没有任何关系要披露。